Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro

Stem Cell Research

Volumn 10, Issue 3, 2013, Pages 325-337

  Liu, Jia ^a,b   Götherström, Cecilia ^a   Forsberg, Magda ^a   Samuelsson, Eva Britt ^a   Wu, Jiang ^b   Calzarossa, Cinzia ^a   Hovatta, Outi ^a   Sundström, Erik ^a,c   Åkesson, Elisabet ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c Stiftelsen Stockholms Sjukhem   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD15 ANTIGEN; CD24 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; HERMES ANTIGEN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; EMBRYO; EMBRYONIC STEM CELL; FETUS; FOXP3+ T CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; NEURAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD; T LYMPHOCYTE; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; FETUS; FORKHEAD TRANSCRIPTION FACTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; NEURAL STEM CELLS; SPINAL CORD; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UP-REGULATION;

EID: 84873902758     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.01.001     Document Type: Article

References (40)

1. Akesson E., Wolmer-Solberg N., Cederarv M., Falci S., Odeberg J. Human neural stem cells and astrocytes, but not neurons, suppress an allogeneic lymphocyte response. Stem Cell Res. 2009, 2(1):56-67.
2. Bommireddy R., Doetschman T. TGFbeta1 and Treg cells: alliance for tolerance. Trends Mol. Med. 2007, 13(11):492-501.
3. Bommireddy R., Bueno O.F., Martin J., Ormsby I., Chen H., Gard C., Molkentin J.D., Boivin G.P., Babcock G.F., Doetschman T. Calcineurin deficiency decreases inflammatory lesions in transforming growth factor beta1-deficient mice. Clin. Exp. Immunol. 2009, 158(3):317-324.
4. Bonnamain V., Mathieux E., Thinard R., Thebault P., Nerriere-Daguin V., Leveque X., Anegon I., Vanhove B., Neveu I., Naveilhan P. Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response. Stem Cells 2012, 30(10):2342-2353.
5. Campos L.S. Beta1 integrins and neural stem cells: making sense of the extracellular environment. Bioessays 2005, 27(7):698-707.
6. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27(3):275-280.
7. Cusimano M., Biziato D., Brambilla E., Donega M., Alfaro-Cervello C., Snider S., Salani G., Pucci F., Comi G., Garcia-Verdugo J.M., De Palma M., Martino G., Pluchino S. Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain 2012, 135(2):447-460.
8. Dummer C.D., Carpio V.N., Goncalves L.F., Manfro R.C., Veronese F.V. FOXP3(+) regulatory T cells: from suppression of rejection to induction of renal allograft tolerance. Transpl. Immunol. 2012, 26(1):1-10.
9. Einstein O., Fainstein N., Vaknin I., Mizrachi-Kol R., Reihartz E., Grigoriadis N., Lavon I., Baniyash M., Lassmann H., Ben-Hur T. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann. Neurol. 2007, 61(3):209-218.
10. Engela A.U., Baan C.C., Dor F.J., Weimar W., Hoogduijn M.J. On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation. Front. Immunol. 2012, 3:126.
11. Fujimoto Y., Abematsu M., Falk A., Tsujimura K., Sanosaka T., Juliandi B., Semi K., Namihira M., Komiya S., Smith A., Nakashima K. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012, 30(6):1163-1173.
12. Gotherstrom C., Ringden O., Tammik C., Zetterberg E., Westgren M., Le Blanc K. Immunologic properties of human fetal mesenchymal stem cells. Am. J. Obstet. Gynecol. 2004, 190(1):239-245.
13. Han K.H., Ro H., Hong J.H., Lee E.M., Cho B., Yeom H.J., Kim M.G., Oh K.H., Ahn C., Yang J. Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. Transpl. Immunol. 2011, 25(1):7-15.
14. Inzunza J., Gertow K., Stromberg M.A., Matilainen E., Blennow E., Skottman H., Wolbank S., Ahrlund-Richter L., Hovatta O. Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. Stem Cells 2005, 23(4):544-549.
15. Johansson S., Price J., Modo M. Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells 2008, 26(9):2444-2454.
16. Karumbayaram S., Novitch B.G., Patterson M., Umbach J.A., Richter L., Lindgren A., Conway A.E., Clark A.T., Goldman S.A., Plath K., Wiedau-Pazos M., Kornblum H.I., Lowry W.E. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27(4):806-811.
17. Krystkowiak P., Gaura V., Labalette M., Rialland A., Remy P., Peschanski M., Bachoud-Levi A.C. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS One 2007, 2(1):e166.
18. Laguna Goya R., Busch R., Mathur R., Coles A.J., Barker R.A. Human fetal neural precursor cells can up-regulate MHC class I and class II expression and elicit CD4 and CD8 T cell proliferation. Neurobiol. Dis. 2011, 41(2):407-414.
19. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Dini G., Egeler R.M., Bacigalupo A., Fibbe W., Ringden O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371(9624):1579-1586.
20. Li L., Baroja M.L., Majumdar A., Chadwick K., Rouleau A., Gallacher L., Ferber I., Lebkowski J., Martin T., Madrenas J., Bhatia M. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004, 22(4):448-456.
21. Li M.O., Wan Y.Y., Flavell R.A. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007, 26(5):579-591.
22. Liu Y., Han S.S., Wu Y., Tuohy T.M., Xue H., Cai J., Back S.A., Sherman L.S., Fischer I., Rao M.S. CD44 expression identifies astrocyte-restricted precursor cells. Dev. Biol. 2004, 276(1):31-46.
23. Morizane A., Li J.Y., Brundin P. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res. 2008, 331(1):323-336.
24. Odeberg J., Piao J.H., Samuelsson E.B., Falci S., Akesson E. Low immunogenicity of in vitro-expanded human neural cells despite high MHC expression. J. Neuroimmunol. 2005, 161(1-2):1-11.
25. Okamura R.M., Lebkowski J., Au M., Priest C.A., Denham J., Majumdar A.S. Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells. J. Neuroimmunol. 2007, 192(1-2):134-144.
26. Piccini P., Pavese N., Hagell P., Reimer J., Bjorklund A., Oertel W.H., Quinn N.P., Brooks D.J., Lindvall O. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128(Pt 12):2977-2986.
27. Preynat-Seauve O., de Rham C., Tirefort D., Ferrari-Lacraz S., Krause K.H., Villard J. Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells. J. Cell. Mol. Med. 2009, 13(9B):3556-3569.
28. Ringden O., Berg B. Correlation between magnitude of MLC and kidney graft survival in intrafamilial transplantation. Tissue Antigens 1977, 10(5):364-372.
29. Robertson N.J., Brook F.A., Gardner R.L., Cobbold S.P., Waldmann H., Fairchild P.J. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(52):20920-20925.
30. Sandner B., Prang P., Rivera F.J., Aigner L., Blesch A., Weidner N. Neural stem cells for spinal cord repair. Cell Tissue Res 2012, 349(1):349-362.
31. Siglienti I., Chan A., Kleinschnitz C., Jander S., Toyka K.V., Gold R., Stoll G. Downregulation of transforming growth factor-beta2 facilitates inflammation in the central nervous system by reciprocal astrocyte/microglia interactions. J. Neuropathol. Exp. Neurol. 2007, 66(1):47-56.
32. Skottman H., Mikkola M., Lundin K., Olsson C., Stromberg A.M., Tuuri T., Otonkoski T., Hovatta O., Lahesmaa R. Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 2005, 23(9):1343-1356.
33. Steiner D., Khaner H., Cohen M., Even-Ram S., Gil Y., Itsykson P., Turetsky T., Idelson M., Aizenman E., Ram R., Berman-Zaken Y., Reubinoff B. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat. Biotechnol. 2010, 28(4):361-364.
34. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
35. Tetzlaff W., Okon E.B., Karimi-Abdolrezaee S., Hill C.E., Sparling J.S., Plemel J.R., Plunet W.T., Tsai E.C., Baptiste D., Smithson L.J., Kawaja M.D., Fehlings M.G., Kwon B.K. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma. 2011, 28(8):1611-1682.
36. Ubiali F., Nava S., Nessi V., Frigerio S., Parati E., Bernasconi P., Mantegazza R., Baggi F. Allorecognition of human neural stem cells by peripheral blood lymphocytes despite low expression of MHC molecules: role of TGF-beta in modulating proliferation. Int. Immunol. 2007, 19(9):1063-1074.
37. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463(7284):1035-1041.
38. Vonderheide R.H., Butler M.O., Liu J.F., Battle T.E., Hirano N., Gribben J.G., Frank D.A., Schultze J.L., Nadler L.M. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity. Int. J. Oncol. 2001, 19(4):791-798.
39. Wang L., Shi J., van Ginkel F.W., Lan L., Niemeyer G., Martin D.R., Snyder E.Y., Cox N.R. Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2. Exp. Neurol. 2009, 216(1):177-183.
40. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474(7350):212-215.